Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | DNMT3A |
Variant | G890D |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | DNMT3A G890D lies within the SAM-dependent MTase C5-type domain of the Dnmt3a protein (UniProt.org). G890D has been identified in sequencing studies (PMID: 22749068, PMID: 25426838, PMID: 25426837), but has not been biochemically characterized and therefore, its effect on Dnmt3a protein function is unknown (PubMed, Oct 2024). |
Associated Drug Resistance | |
Category Variants Paths |
DNMT3A mutant DNMT3A G890D |
Transcript | NM_022552.5 |
gDNA | chr2:g.25234349C>T |
cDNA | c.2669G>A |
Protein | p.G890D |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017003526.1 | chr2:g.25234349C>T | c.2669G>A | p.G890D | RefSeq | GRCh38/hg38 |
XM_005264175.6 | chr2:g.25234349C>T | c.2669G>A | p.G890D | RefSeq | GRCh38/hg38 |
NM_022552 | chr2:g.25234349C>T | c.2669G>A | p.G890D | RefSeq | GRCh38/hg38 |
XM_005264175.5 | chr2:g.25234349C>T | c.2669G>A | p.G890D | RefSeq | GRCh38/hg38 |
XM_017003526 | chr2:g.25234349C>T | c.2669G>A | p.G890D | RefSeq | GRCh38/hg38 |
XM_017003526.2 | chr2:g.25234349C>T | c.2669G>A | p.G890D | RefSeq | GRCh38/hg38 |
NM_022552.4 | chr2:g.25234349C>T | c.2669G>A | p.G890D | RefSeq | GRCh38/hg38 |
XM_005264175 | chr2:g.25234349C>T | c.2669G>A | p.G890D | RefSeq | GRCh38/hg38 |
NM_175629.2 | chr2:g.25234349C>T | c.2669G>A | p.G890D | RefSeq | GRCh38/hg38 |
NM_175629 | chr2:g.25234349C>T | c.2669G>A | p.G890D | RefSeq | GRCh38/hg38 |
NM_022552.5 | chr2:g.25234349C>T | c.2669G>A | p.G890D | RefSeq | GRCh38/hg38 |
NM_175629.2 | chr2:g.25234349C>T | c.2669G>A | p.G890D | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|